AZD3043
Phase 1Withdrawn 1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety, Tolerability, Pharmacokinetics, Sedation
Trial Timeline
Mar 1, 2010 → Apr 1, 2010
NCT ID
NCT01086813About AZD3043
AZD3043 is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01086813. Target conditions include Safety, Tolerability, Pharmacokinetics.
What happened to similar drugs?
3 of 4 similar drugs in Safety were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01086813 | Phase 1 | Withdrawn |
| NCT00984880 | Phase 1 | Completed |
| NCT00918515 | Phase 1 | Completed |
Competing Products
20 competing products in Safety